{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,24]],"date-time":"2026-06-24T00:44:27Z","timestamp":1782261867722,"version":"3.54.5"},"reference-count":45,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2023,6,1]],"date-time":"2023-06-01T00:00:00Z","timestamp":1685577600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,6,1]],"date-time":"2023-06-01T00:00:00Z","timestamp":1685577600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,6,1]],"date-time":"2023-06-01T00:00:00Z","timestamp":1685577600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2023,6,1]],"date-time":"2023-06-01T00:00:00Z","timestamp":1685577600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2023,6,1]],"date-time":"2023-06-01T00:00:00Z","timestamp":1685577600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2023,6,1]],"date-time":"2023-06-01T00:00:00Z","timestamp":1685577600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2023,6,1]],"date-time":"2023-06-01T00:00:00Z","timestamp":1685577600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/100007210","name":"Varian Medical Systems","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100007210","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinical-breast-cancer.com","clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Clinical Breast Cancer"],"published-print":{"date-parts":[[2023,6]]},"DOI":"10.1016\/j.clbc.2023.01.012","type":"journal-article","created":{"date-parts":[[2023,2,1]],"date-time":"2023-02-01T02:39:37Z","timestamp":1675219177000},"page":"369-377","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":4,"title":["Long-Term Adherence to Adjuvant Endocrine Therapy Following Various Radiotherapy Modalities in Early Stage Hormone Receptor Positive Breast Cancer"],"prefix":"10.1016","volume":"23","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-7310-288X","authenticated-orcid":false,"given":"Kristin A.","family":"Ward","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Donald A.","family":"Muller","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sunil W.","family":"Dutta","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jasmine","family":"Malhi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jason C.","family":"Sanders","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christopher K.","family":"Luminais","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Trish A.","family":"Millard","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Timothy N.","family":"Showalter","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shayna L.","family":"Showalter","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Einsley-Marie","family":"Janowski","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"9793","key":"10.1016\/j.clbc.2023.01.012_bib0001","doi-asserted-by":"crossref","first-page":"771","DOI":"10.1016\/S0140-6736(11)60993-8","article-title":"Relevance of breast cancer hormone receptors and other factors to the efficacy of adjuvant tamoxifen: patient-level meta-analysis of randomized trials","volume":"378","year":"2011","journal-title":"Lancet"},{"issue":"9472","key":"10.1016\/j.clbc.2023.01.012_bib0002","doi-asserted-by":"crossref","first-page":"1687","DOI":"10.1016\/S0140-6736(05)66544-0","article-title":"Effects of chemotherapy and hormonal therapy for early breast cancer on recurrence and 15-year survival: an overview of the randomized trials","volume":"365","year":"2005","journal-title":"Lancet"},{"issue":"9869","key":"10.1016\/j.clbc.2023.01.012_bib0003","doi-asserted-by":"crossref","first-page":"805","DOI":"10.1016\/S0140-6736(12)61963-1","article-title":"Long-term effects of continuing adjuvant tamoxifen to 10 years versus stopping at 5 years after diagnosis of oestrogen receptor-positive breast cancer: ATLAS, a randomized trial","volume":"381","author":"Davies","year":"2013","journal-title":"Lancet"},{"issue":"12","key":"10.1016\/j.clbc.2023.01.012_bib0004","doi-asserted-by":"crossref","first-page":"1135","DOI":"10.1016\/S1470-2045(10)70257-6","article-title":"Effect of anastrozole and tamoxifen as adjuvant treatment for early-stage breast cancer: 10-year analysis of the ATAC trial","volume":"11","author":"Cuzick","year":"2010","journal-title":"Lancet Oncol"},{"issue":"1","key":"10.1016\/j.clbc.2023.01.012_bib0005","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1016\/S1470-2045(07)70385-6","article-title":"Effect of anastrozole and tamoxifen as adjuvant treatment for early-stage breast cancer: 100-month analysis of the ATAC trial","volume":"9","author":"Forbes","year":"2008","journal-title":"Lancet Oncol"},{"issue":"3","key":"10.1016\/j.clbc.2023.01.012_bib0006","doi-asserted-by":"crossref","first-page":"509","DOI":"10.1200\/JCO.2009.23.1274","article-title":"Meta-analysis of breast cancer outcomes in adjuvant trials of aromatase inhibitors versus tamoxifen","volume":"28","author":"Dowsett","year":"2010","journal-title":"J Clin Oncol"},{"issue":"2","key":"10.1016\/j.clbc.2023.01.012_bib0007","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1007\/s10549-007-9548-1","article-title":"Recognition and management of treatment-related side effects for breast cancer patients receiving adjuvant endocrine therapy","volume":"107","author":"Cella","year":"2008","journal-title":"Breast Cancer Res Treat"},{"issue":"23","key":"10.1016\/j.clbc.2023.01.012_bib0008","doi-asserted-by":"crossref","first-page":"3784","DOI":"10.1200\/JCO.2009.26.3756","article-title":"American Society of Clinical Oncology clinical practice guideline: update on adjuvant endocrine therapy for women with hormone receptor-positive breast cancer","volume":"28","author":"Burstein","year":"2010","journal-title":"J Clin Oncol"},{"issue":"4","key":"10.1016\/j.clbc.2023.01.012_bib0009","doi-asserted-by":"crossref","first-page":"556","DOI":"10.1200\/JCO.2007.11.5451","article-title":"Adherence to initial adjuvant anastrozole therapy among women with early-stage breast cancer","volume":"26","author":"Partridge","year":"2008","journal-title":"J Clin Oncol"},{"issue":"5","key":"10.1016\/j.clbc.2023.01.012_bib0010","doi-asserted-by":"crossref","first-page":"1421","DOI":"10.1158\/1078-0432.CCR-20-3974","article-title":"Early Discontinuation of endocrine therapy and recurrence of breast cancer among premenopausal women","volume":"27","author":"Collin","year":"2021","journal-title":"Clin Cancer Res"},{"key":"10.1016\/j.clbc.2023.01.012_bib0011","doi-asserted-by":"crossref","unstructured":"Goldberg M., Sutradhar R., Paszat L., et\u00a0al. Abstract P5-12-06: Non-adherence to endocrine therapy is associated with a significant increased risk of local recurrence in women \u226565 years with stage T1N0 breast cancer treated with adjuvant endocrine therapy alone after breast-conserving surgery. Cancer Res. 2020;80(4 Supplement). p. P5-12-06-P5-12-06.","DOI":"10.1158\/1538-7445.SABCS19-P5-12-06"},{"issue":"4","key":"10.1016\/j.clbc.2023.01.012_bib0012","doi-asserted-by":"crossref","first-page":"987","DOI":"10.1016\/j.ijrobp.2009.02.031","article-title":"Accelerated partial breast irradiation consensus statement from the American Society for Radiation Oncology (ASTRO)","volume":"74","author":"Smith","year":"2009","journal-title":"Int J Radiat Oncol Biol Phys"},{"issue":"10215","key":"10.1016\/j.clbc.2023.01.012_bib0013","doi-asserted-by":"crossref","first-page":"2155","DOI":"10.1016\/S0140-6736(19)32514-0","article-title":"Long-term primary results of accelerated partial breast irradiation after breast-conserving surgery for early-stage breast cancer: a randomised, phase 3, equivalence trial","volume":"394","author":"Vicini","year":"2019","journal-title":"Lancet"},{"issue":"35","key":"10.1016\/j.clbc.2023.01.012_bib0014","doi-asserted-by":"crossref","first-page":"4175","DOI":"10.1200\/JCO.20.00650","article-title":"Accelerated partial-breast irradiation compared with whole-breast irradiation for early breast cancer: long-term results of the randomized phase III APBI-IMRT-florence trial","volume":"38","author":"Meattini","year":"2020","journal-title":"J Clin Oncol"},{"issue":"9735","key":"10.1016\/j.clbc.2023.01.012_bib0015","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1016\/S0140-6736(10)60837-9","article-title":"Targeted intraoperative radiotherapy versus whole breast radiotherapy for breast cancer (TARGIT-A trial): an international, prospective, randomized, non-inferiority phase 3 trial","volume":"376","author":"Vaidya","year":"2010","journal-title":"Lancet"},{"issue":"12","key":"10.1016\/j.clbc.2023.01.012_bib0016","doi-asserted-by":"crossref","first-page":"723","DOI":"10.1038\/s41571-020-00444-2","article-title":"Intraoperative radiotherapy for early breast cancer - insufficient evidence to change practice","volume":"17","author":"Sasieni","year":"2020","journal-title":"Nat Rev Clin Oncol"},{"issue":"3","key":"10.1016\/j.clbc.2023.01.012_bib0017","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1016\/j.brachy.2019.02.005","article-title":"Implementation of an HDR brachytherapy-based breast IORT program: initial experiences","volume":"18","author":"Dutta","year":"2019","journal-title":"Brachytherapy"},{"key":"10.1016\/j.clbc.2023.01.012_bib0018","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1016\/j.radonc.2021.11.019","article-title":"An examination of nationwide trends in accelerated partial breast irradiation - The replacement of breast brachytherapy with intraoperative radiotherapy and external beam radiation","volume":"166","author":"Ladbury","year":"2022","journal-title":"Radiother Oncol"},{"issue":"27","key":"10.1016\/j.clbc.2023.01.012_bib0019","doi-asserted-by":"crossref","first-page":"4120","DOI":"10.1200\/JCO.2009.25.9655","article-title":"Early discontinuation and nonadherence to adjuvant hormonal therapy in a cohort of 8,769 early-stage breast cancer patients","volume":"28","author":"Hershman","year":"2010","journal-title":"J Clin Oncol"},{"issue":"11","key":"10.1016\/j.clbc.2023.01.012_bib0020","doi-asserted-by":"crossref","first-page":"1763","DOI":"10.1038\/sj.bjc.6604758","article-title":"Cohort study examining tamoxifen adherence and its relationship to mortality in women with breast cancer","volume":"99","author":"McCowan","year":"2008","journal-title":"Br J Cancer"},{"issue":"1","key":"10.1016\/j.clbc.2023.01.012_bib0021","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1016\/j.ijrobp.2016.04.035","article-title":"A novel form of breast intraoperative radiation therapy with CT-guided high-dose-rate brachytherapy: results of a prospective phase 1 clinical trial","volume":"96","author":"Showalter","year":"2016","journal-title":"Int J Radiat Oncol Biol Phys"},{"issue":"19","key":"10.1016\/j.clbc.2023.01.012_bib0022","doi-asserted-by":"crossref","first-page":"1937","DOI":"10.1056\/NEJMoa032646","article-title":"Postoperative concurrent radiotherapy and chemotherapy for high-risk squamous-cell carcinoma of the head and neck","volume":"350","author":"Cooper","year":"2004","journal-title":"N Engl J Med"},{"issue":"3","key":"10.1016\/j.clbc.2023.01.012_bib0023","doi-asserted-by":"crossref","first-page":"266","DOI":"10.1016\/S1470-2045(14)71221-5","article-title":"Breast-conserving surgery with or without irradiation in women aged 65 years or older with early breast cancer (PRIME II): a randomised controlled trial","volume":"16","author":"Kunkler","year":"2015","journal-title":"Lancet Oncol"},{"issue":"10","key":"10.1016\/j.clbc.2023.01.012_bib0024","doi-asserted-by":"crossref","first-page":"971","DOI":"10.1056\/NEJMoa040587","article-title":"Lumpectomy plus Tamoxifen with or without irradiation in women 70 years of age or older with early breast cancer","volume":"351","author":"Hughes","year":"2004","journal-title":"N Engl J Med"},{"issue":"18","key":"10.1016\/j.clbc.2023.01.012_bib0025","doi-asserted-by":"crossref","first-page":"3266","DOI":"10.1002\/cncr.32192","article-title":"Nonadherent behaviors among young women on adjuvant endocrine therapy for breast cancer","volume":"125","author":"Wassermann","year":"2019","journal-title":"Cancer"},{"issue":"9917","key":"10.1016\/j.clbc.2023.01.012_bib0026","doi-asserted-by":"crossref","first-page":"603","DOI":"10.1016\/S0140-6736(13)61950-9","article-title":"Risk-adapted targeted intraoperative radiotherapy versus whole-breast radiotherapy for breast cancer: 5-year results for local control and overall survival from the TARGIT-A randomised trial","volume":"383","author":"Vaidya","year":"2014","journal-title":"Lancet"},{"issue":"6","key":"10.1016\/j.clbc.2023.01.012_bib0027","doi-asserted-by":"crossref","first-page":"513","DOI":"10.1056\/NEJMoa0906260","article-title":"Long-term results of hypofractionated radiation therapy for breast cancer","volume":"362","author":"Whelan","year":"2010","journal-title":"N Engl J Med"},{"issue":"9618","key":"10.1016\/j.clbc.2023.01.012_bib0028","doi-asserted-by":"crossref","first-page":"1098","DOI":"10.1016\/S0140-6736(08)60348-7","article-title":"START Trialists\u2019 Group; Bentzen S.M., Agrawal R.K., Aird E.G., et\u00a0al. The UK standardisation of breast radiotherapy (START) trial B of radiotherapy hypofractionation for treatment of early breast cancer: a randomised trial","volume":"371","year":"2008","journal-title":"Lancet"},{"issue":"2","key":"10.1016\/j.clbc.2023.01.012_bib0029","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1016\/j.prro.2016.09.007","article-title":"Accelerated partial breast irradiation: executive summary for the update of an ASTRO evidence-based consensus statement","volume":"7","author":"Correa","year":"2017","journal-title":"Pract Radiat Oncol"},{"key":"10.1016\/j.clbc.2023.01.012_bib0030","doi-asserted-by":"crossref","first-page":"753209","DOI":"10.3389\/fonc.2021.753209","article-title":"Comparing hypofractionated with conventional fractionated radiotherapy after breast-conserving surgery for early breast cancer: a meta-analysis of randomized controlled trials","volume":"11","author":"Gu","year":"2021","journal-title":"Front Oncol"},{"issue":"3","key":"10.1016\/j.clbc.2023.01.012_bib0031","doi-asserted-by":"crossref","first-page":"353","DOI":"10.1111\/tbj.13491","article-title":"Changing practice patterns of adjuvant radiation among elderly women with early stage breast cancer in the United States from 2004 to 2014","volume":"26","author":"Reyes","year":"2020","journal-title":"Breast J"},{"issue":"3","key":"10.1016\/j.clbc.2023.01.012_bib0032","doi-asserted-by":"crossref","first-page":"S52","DOI":"10.1016\/j.brachy.2017.04.085","article-title":"Fractionation trends in breast cancer and implications in partial breast irradiation","volume":"16","author":"Trifiletti","year":"2017","journal-title":"Brachytherapy"},{"issue":"10215","key":"10.1016\/j.clbc.2023.01.012_bib0033","doi-asserted-by":"crossref","first-page":"2165","DOI":"10.1016\/S0140-6736(19)32515-2","article-title":"External beam accelerated partial breast irradiation versus whole breast irradiation after breast conserving surgery in women with ductal carcinoma in situ and node-negative breast cancer (RAPID): a randomised controlled trial","volume":"394","author":"Whelan","year":"2019","journal-title":"Lancet"},{"issue":"9","key":"10.1016\/j.clbc.2023.01.012_bib0034","doi-asserted-by":"crossref","first-page":"3458","DOI":"10.1245\/s10434-020-08430-9","article-title":"Evaluating the long-term impact of a cooperative group trial on radiation use and adjuvant endocrine therapy adherence among older women","volume":"27","author":"Keim-Malpass","year":"2020","journal-title":"Ann Surg Oncol"},{"issue":"9804","key":"10.1016\/j.clbc.2023.01.012_bib0035","doi-asserted-by":"crossref","first-page":"1707","DOI":"10.1016\/S0140-6736(11)61629-2","article-title":"Effect of radiotherapy after breast-conserving surgery on 10-year recurrence and 15-year breast cancer death: meta-analysis of individual patient data for 10,801 women in 17 randomised trials","volume":"378","author":"Early Breast Cancer Trialists\u2019 Collaborative Group (EBCTCG); Darby","year":"2011","journal-title":"Lancet"},{"issue":"10","key":"10.1016\/j.clbc.2023.01.012_bib0036","doi-asserted-by":"crossref","first-page":"963","DOI":"10.1056\/NEJMoa040595","article-title":"Tamoxifen with or without breast irradiation in women 50 years of age or older with early breast cancer","volume":"351","author":"Fyles","year":"2004","journal-title":"N Engl J Med"},{"issue":"1","key":"10.1016\/j.clbc.2023.01.012_bib0037","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1016\/j.jamcollsurg.2007.07.015","article-title":"Mortality impact of less-than-standard therapy in older breast cancer patients","volume":"206","author":"Yood","year":"2008","journal-title":"J Am Coll Surg"},{"issue":"13","key":"10.1016\/j.clbc.2023.01.012_bib0038","doi-asserted-by":"crossref","first-page":"1683","DOI":"10.1200\/JCO.2006.09.2106","article-title":"Breast cancer mortality trends in the United States according to estrogen receptor status and age at diagnosis","volume":"25","author":"Jatoi","year":"2007","journal-title":"J Clin Oncol"},{"issue":"3","key":"10.1016\/j.clbc.2023.01.012_bib0039","doi-asserted-by":"crossref","first-page":"805","DOI":"10.1007\/s10549-020-05908-8","article-title":"Predicting adjuvant endocrine therapy initiation and adherence among older women with early-stage breast cancer","volume":"184","author":"Meneveau","year":"2020","journal-title":"Breast Cancer Res Treat"},{"key":"10.1016\/j.clbc.2023.01.012_bib0040","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1186\/1471-2407-13-401","article-title":"Joint pain severity predicts premature discontinuation of aromatase inhibitors in breast cancer survivors","volume":"13","author":"Chim","year":"2013","journal-title":"BMC Cancer"},{"issue":"11","key":"10.1016\/j.clbc.2023.01.012_bib0041","doi-asserted-by":"crossref","first-page":"2680","DOI":"10.1200\/JCO.2002.08.137","article-title":"Adjuvant tamoxifen prescription in women 65 years and older with primary breast cancer","volume":"20","author":"Silliman","year":"2002","journal-title":"J Clin Oncol"},{"issue":"2","key":"10.1016\/j.clbc.2023.01.012_bib0042","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1007\/s10549-017-4317-2","article-title":"Breast cancer oral anti-cancer medication adherence: a systematic review of psychosocial motivators and barriers","volume":"165","author":"Lin","year":"2017","journal-title":"Breast Cancer Res Treat"},{"issue":"3","key":"10.1016\/j.clbc.2023.01.012_bib0043","doi-asserted-by":"crossref","first-page":"E50","DOI":"10.1188\/14.CJON.E50-E57","article-title":"Reasons for nonadherence to tamoxifen and aromatase inhibitors for the treatment of breast cancer: a literature review","volume":"18","author":"Sawesi","year":"2014","journal-title":"Clin J Oncol Nurs"},{"issue":"1","key":"10.1016\/j.clbc.2023.01.012_bib0044","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1002\/cncr.30318","article-title":"Perceived barriers to treatment predict adherence to aromatase inhibitors among breast cancer survivors","volume":"123","author":"Brier","year":"2017","journal-title":"Cancer"},{"issue":"16","key":"10.1016\/j.clbc.2023.01.012_bib0045","doi-asserted-by":"crossref","first-page":"3309","DOI":"10.1200\/JCO.2004.11.064","article-title":"Patient beliefs and tamoxifen discontinuance in older women with estrogen receptor\u2013positive breast cancer","volume":"22","author":"Fink","year":"2004","journal-title":"J Clin Oncol"}],"container-title":["Clinical Breast Cancer"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1526820923000277?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1526820923000277?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,26]],"date-time":"2025-10-26T21:24:25Z","timestamp":1761513865000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1526820923000277"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,6]]},"references-count":45,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2023,6]]}},"alternative-id":["S1526820923000277"],"URL":"https:\/\/doi.org\/10.1016\/j.clbc.2023.01.012","relation":{},"ISSN":["1526-8209"],"issn-type":[{"value":"1526-8209","type":"print"}],"subject":[],"published":{"date-parts":[[2023,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Long-Term Adherence to Adjuvant Endocrine Therapy Following Various Radiotherapy Modalities in Early Stage Hormone Receptor Positive Breast Cancer","name":"articletitle","label":"Article Title"},{"value":"Clinical Breast Cancer","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.clbc.2023.01.012","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}